{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:21:28Z","timestamp":1761708088441},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,6,26]],"date-time":"2007-06-26T00:00:00Z","timestamp":1182816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11883-007-0031-6","type":"journal-article","created":{"date-parts":[[2007,6,25]],"date-time":"2007-06-25T11:20:47Z","timestamp":1182770447000},"page":"261-265","source":"Crossref","is-referenced-by-count":16,"title":["The strengths and limitations of the ApoB\/ApoA-I ratio to predict the risk of vascular disease: a hegelian analysis"],"prefix":"10.1007","volume":"9","author":[{"given":"Allan D.","family":"Sniderman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,26]]},"reference":[{"key":"31_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","volume":"259","author":"P.J. Barter","year":"2006","unstructured":"Barter PJ, Ballantyne CM, Carmena R, et al.: ApoB versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person\/ten-country panel. J Intern Med 2006, 259:247\u2013258.","journal-title":"J Intern Med"},{"key":"31_CR2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2796.2006.01644.x","volume":"259","author":"A. Thompson","year":"2006","unstructured":"Thompson A, Danesh J: Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B\/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med 2006, 259:481\u2013492.","journal-title":"J Intern Med"},{"key":"31_CR3","first-page":"497","volume-title":"Contemporary Cardiology: Cardiovascular Biomarkers: Pathophysiology and Disease Management","author":"R.L. Dunbar","year":"2006","unstructured":"Dunbar RL, Rader DJ.: Measurement of atherogenic lipoproteins in cardiovascular risk assessment. In Contemporary Cardiology: Cardiovascular Biomarkers: Pathophysiology and Disease Management. Edited by Morrow DA. Totowa, NJ: Humana Press; 2006:497\u2013517."},{"key":"31_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/qjmed\/hcl027","volume":"99","author":"D.C. Chan","year":"2006","unstructured":"Chan DC, Watts GF: Apolipoproteins as markers and managers of coronary risk. QJ Med 2006, 99:277\u2013287.","journal-title":"QJ Med"},{"key":"31_CR5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","volume":"259","author":"G. Walldius","year":"2006","unstructured":"Walldius G, Jungner I: The apoB\/apoA-1 ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy\u2014a review of the evidence. J Intern Med 2006, 259:493\u2013519.","journal-title":"J Intern Med"},{"key":"31_CR6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.ATV.0000255580.73689.8e","volume":"27","author":"M. Benn","year":"2007","unstructured":"Benn M, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A: Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study. Aterioscler Thromb Vasc Biol 2007, 27:661\u2013670.","journal-title":"Aterioscler Thromb Vasc Biol"},{"key":"31_CR7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.CIR.101.5.477","volume":"101","author":"A.M. Gotto","year":"2000","unstructured":"Gotto AM, Whitney E, Stein EA, et al.: Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air force\/Texas Coronary Atherosclerosis Prevention Study (AFCAPS\/TexCAPS). Circulation 2000, 101:477\u2013484.","journal-title":"Circulation"},{"key":"31_CR8","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/01.ATV.20.11.2408","volume":"20","author":"J.E. Lennep van","year":"2000","unstructured":"van Lennep JE, Westerveld HT, van Lennep HW, et al.: Apolipoprotein concentrations during treatment and recurrent coronary artery disease events. Arterioscler Thromb Vasc Biol 2000, 20:2408\u20132413.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"31_CR9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/hc1002.105136","volume":"105","author":"R.J. Simes","year":"2002","unstructured":"Simes RJ, Marschner IC, Hunt D, et al.: Relationship between lipid levels and clinical outcomes in the long-term intervention with pravastatin in the ischemic disease (LIPID) trial. To what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? Circulation 2002, 105:1162\u20131169.","journal-title":"Circulation"},{"key":"31_CR10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.297.5.499","volume":"297","author":"S.J. Nicholls","year":"2007","unstructured":"Nicholls SJ, Tuzcu EM, Sipahi I, et al.: Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007, 297:499\u2013508.","journal-title":"JAMA"},{"key":"31_CR11","first-page":"713","volume":"II","author":"J.J. Kastelein","year":"2006","unstructured":"Kastelein JJ, Holme I, Barter P, et al.: Superiority of apoB\/apoAI ratio for predicting cardiovascular risk in pooled analyses of the incremental decrease in endpoints through aggressive lipid-lowering (IDEAL) and treating to new targets (TNT) trials. Circulation 2006, II:713.","journal-title":"Circulation"},{"key":"31_CR12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1515\/CCLM.2004.254","volume":"42","author":"G. Walldius","year":"2004","unstructured":"Walldius G, Jungner I, Aastveit AH, et al.: The apoB\/apoA-I ratio is better than the cholesterol ratios to estimate the balance between the plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 2004, 42:1355\u20131363.","journal-title":"Clin Chem Lab Med"},{"key":"31_CR13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S. Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al.: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937\u2013952.","journal-title":"Lancet"},{"key":"31_CR14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11883-006-0033-9","volume":"8","author":"N. Khuseyinova","year":"2006","unstructured":"Khuseyinova N, Koenig W: Apolipoprotein A-I and risk for cardiovascular diseases. Curr Atheroscler Rep 2006, 8:365\u2013373.","journal-title":"Curr Atheroscler Rep"},{"key":"31_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2796.2006.01647.x","volume":"259","author":"P.J. Barter","year":"2006","unstructured":"Barter PJ, Rye KA: The rationale for using apo A-I as a clinical marker for cardiovascular risk. J Intern Med 2006, 259:447\u2013454.","journal-title":"J Intern Med"},{"key":"31_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.hco.0000231405.76930.a0","volume":"21","author":"G. Lewis","year":"2006","unstructured":"Lewis G: Determinants of plasma HDL concentrations and reverse cholesterol transport. Curr Opin Cardiol 2006, 21:345\u2013352.","journal-title":"Curr Opin Cardiol"},{"key":"31_CR17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinbiochem.2006.06.014","volume":"40","author":"A.J. Tremblay","year":"2007","unstructured":"Tremblay AJ, Sniderman AD, Gagne C, et al.: Differential impact of plasma triglycerides on HDL-cholesterol and HDL-apo A-1 in a large cohort. Clin Biochem 2007, 40:25\u201329.","journal-title":"Clin Biochem"},{"key":"31_CR18","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","volume":"290","author":"S.E. Nissen","year":"2003","unstructured":"Nissen SE, Tsunoda T, Tuzcu EM, et al.: Effect of recombinant ApoA-1 Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 2003, 290:2292\u20132300.","journal-title":"JAMA"},{"key":"31_CR19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.CIR.0000159351.95399.50","volume":"111","author":"S.J. Nicholls","year":"2005","unstructured":"Nicholls SJ, Dusting GJ, Cutri B, et al.: Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 2005, 111:1543\u20131550.","journal-title":"Circulation"},{"key":"31_CR20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2796.2006.01648.x","volume":"259","author":"S. Marcovina","year":"2006","unstructured":"Marcovina S, Packard CJ: Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med 2006, 259:437\u2013446.","journal-title":"J Intern Med"},{"key":"31_CR21","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.ATV.0000176191.64314.07","volume":"25","author":"R.R. Sankatsing","year":"2005","unstructured":"Sankatsing RR, Fouchier SW, de Haan S, et al.: Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol 2005, 25:1979\u20131984.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"31_CR22","doi-asserted-by":"crossref","unstructured":"Jansen AC, van Aalst-Cohen ES, Tanck MW, et al.: The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J Intern Med 2004, C","DOI":"10.1111\/j.1365-2796.2004.01405.x"},{"key":"31_CR23","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/01.ATV.0000078520.89539.77","volume":"23","author":"R.R. Singaraja","year":"2003","unstructured":"Singaraja RR, Brunham LR, Visscher H, et al.: Efflux and atherosclerosis. The clinical and biocehmical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 2003, 23:1322\u20131332.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"31_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.mol.0000162318.47172.ef","volume":"16","author":"G.K. Hovingh","year":"2007","unstructured":"Hovingh GK, de Groot E, van der Steeg W, et al.: Inherited disorders of HDL metabolism and atherosclerosis. Curr Opin Lipidol 2007, 16:139\u2013145.","journal-title":"Curr Opin Lipidol"},{"key":"31_CR25","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0022-2275(20)31498-X","volume":"42","author":"A.D. Attie","year":"2001","unstructured":"Attie AD, Kastelein JP, Hayden MR: Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res 2001, 42:1717\u20131726.","journal-title":"J Lipid Res"},{"key":"31_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cca.2006.10.001","volume":"377","author":"M. Miller","year":"2007","unstructured":"Miller M, Rhyne J, Hong SH, et al.: Do mutations causing low HDL-C promote increased carotid intima-media thickness? Clin Chim Acta 2007, 377:273\u2013275.","journal-title":"Clin Chim Acta"},{"key":"31_CR27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/01.ATV.2.1.16","volume":"2","author":"E.J. Schaefer","year":"1982","unstructured":"Schaefer EJ, Heaton WH, Wetzel MG, Brewer HB Jr: Plasma apolipoprotein a-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arterioscler Thromb Vasc Biol 1982, 2:16\u201326.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"31_CR28","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/01.ATV.13.12.1728","volume":"13","author":"J. Genest Jr","year":"1993","unstructured":"Genest J Jr, Bard JM, Fruchart JC, et al.: Familial hypoalphalipoproteinemia in premature coronary artery disease. Arterioscler Thromb Vasc Biol 1993, 13:1728\u20131737.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"31_CR29","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2004.06.070","volume":"44","author":"G.K. Hovingh","year":"2004","unstructured":"Hovingh GK, Brownlie A, Bisoendial RJ, et al.: A novel apoA-I mutation (L1789) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. J Am Coll Cardiol 2004, 44:1429\u20131435.","journal-title":"J Am Coll Cardiol"},{"key":"31_CR30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)37433-2","volume":"38","author":"J.A. Kuivenhoven","year":"1997","unstructured":"Kuivenhoven JA, Pritchard H, Hill J, et al.: The molecular pathology of lecithin:cholesterol acyltransferase (LCAT). J Lipid Res 1997, 38:191\u2013205.","journal-title":"J Lipid Res"},{"key":"31_CR31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.RES.0000237920.70451.ad","volume":"99","author":"R.R. Singaraja","year":"2006","unstructured":"Singaraja RR, Visscher H, James ER, et al.: Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro. Circ Res 2006, 99:389\u2013397.","journal-title":"Circ Res"},{"key":"31_CR32","doi-asserted-by":"crossref","unstructured":"Kiss RS, Kavaslar N, Okuhira KI, et al.: Genetic etiology of isolated low HDL syndrome. Incidence and heterogeneity of efflux defects. Arterioscler Thromb Vasc Biol 2007, Feb 15:[Epub ahead of print].","DOI":"10.1161\/ATVBAHA.106.137646"},{"key":"31_CR33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/ATVBAHA.106.138990","volume":"27","author":"L. Sarov-Blat","year":"2007","unstructured":"Sarov-Blat L, Kiss RS, Haidar B, et al.: Predominance of a proinflammatory phenotype in monocyte-derived macrophages from subjects with low plasma HDL-cholesterol. Arterioscler Thromb Vasc Biol 2007, 27:1115\u20131122.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"31_CR34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.ATV.0000256728.60226.77","volume":"27","author":"A.R. Tall","year":"2007","unstructured":"Tall AR: The failure of torcetrapib: was it the molecule or the mechanism? Arterioscler Thromb Vasc Biol 2007, 27:257\u2013260.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"31_CR35","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0140-6736(93)92933-K","volume":"342","author":"D.J. Rader","year":"1993","unstructured":"Rader DJ, Ikewaki K, Duverger N, et al.: Very low high-density lipoproteins without coronary atherosclerosis. Lancet 1993, 342:1455\u20131458.","journal-title":"Lancet"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-007-0031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-007-0031-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-007-0031-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,15]],"date-time":"2021-08-15T16:14:44Z","timestamp":1629044084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-007-0031-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,26]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1007\/s11883-007-0031-6","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,26]]}}}